Ascentage Pharma Group Inc.
Clinical trials sponsored by Ascentage Pharma Group Inc., explained in plain language.
-
Trial tests new combo for Tough-to-Treat cancers
Disease control TerminatedThis study tested the safety and effectiveness of combining two drugs, APG-1387 and toripalimab, for people with advanced solid tumors that had stopped responding to standard treatments. The trial involved about 40 participants with specific cancers, including colorectal cancer, …
Phase: PHASE1, PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo tested for Tough-to-Treat pancreatic cancer
Disease control TerminatedThis study tested a new drug called APG-1387, given alongside standard chemotherapy drugs, for people with advanced pancreatic cancer that had stopped responding to their first treatment. The main goals were to find a safe dose and see if the combination could help control the ca…
Phase: PHASE1, PHASE2 • Sponsor: Ascentage Pharma Group Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC